Literature DB >> 11567048

Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways.

M M Sousa1, S Du Yan, R Fernandes, A Guimaraes, D Stern, M J Saraiva.   

Abstract

Familial amyloid polyneuropathy (FAP) is a neurodegenerative disorder associated with extracellular deposition of mutant transthyretin (TTR) amyloid fibrils, particularly in the peripheral nervous system. We have hypothesized that binding of TTR fibrils to the receptor for advanced glycation end products (RAGE) on critical cellular targets is associated with a destructive stress response underlying peripheral nerve dysfunction. Analysis of nerve biopsy samples from patients with FAP (n = 16) at different stages of disease (0-3), compared with age-matched controls (n = 4), by semiquantitative immunohistology and in situ hybridization showed increased levels of RAGE, beginning at the earliest stages of the disease (FAP 0; p < 0.02) and especially localized in axons. Upregulation of proinflammatory cytokines (tumor necrosis factor-alpha and interleukin-1beta) (approximately threefold; p < 0.02) and the inducible form of nitric oxide synthase (iNOS) ( approximately 2.5-fold; p < 0.04) was also observed in a distribution overlapping RAGE expression. Tyrosine nitration and increased activated caspase-3 in axons from FAP patients (p < 0.03) were apparent. Although these data suggest the presence of ongoing neuronal stress, there was no upregulation of neurotrophins (nerve growth factor and neurotrophin-3) in FAP nerves. Studies on cultured neuronal-like, Schwann, and endothelial cells incubated with TTR fibrils displayed RAGE-dependent expression of cytokines and iNOS at early times (6 and 12 hr, respectively), followed by later (24 hr) activation of caspase-3 and DNA fragmentation. We propose that the interaction of TTR fibrils with RAGE may contribute to cellular stress and toxicity in FAP. Furthermore, there is an apparent lack of responsiveness of Schwann cells in FAP nerve to provide neurotrophic factors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11567048      PMCID: PMC6762914     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  40 in total

1.  RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.

Authors:  M A Hofmann; S Drury; C Fu; W Qu; A Taguchi; Y Lu; C Avila; N Kambham; A Bierhaus; P Nawroth; M F Neurath; T Slattery; D Beach; J McClary; M Nagashima; J Morser; D Stern; A M Schmidt
Journal:  Cell       Date:  1999-06-25       Impact factor: 41.582

2.  Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis.

Authors:  S D Yan; H Zhu; A Zhu; A Golabek; H Du; A Roher; J Yu; C Soto; A M Schmidt; D Stern; M Kindy
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

3.  Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control.

Authors:  Z L Chu; T A McKinsey; L Liu; J J Gentry; M H Malim; D W Ballard
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

4.  Familial amyloid polyneuropathy: an electron microscope study of the peripheral nerve in five cases. I. Interstitial changes.

Authors:  A Coimbra; C Andrade
Journal:  Brain       Date:  1971       Impact factor: 13.501

Review 5.  Amyloid fibril toxicity in Alzheimer's disease and diabetes.

Authors:  A Lorenzo; B A Yankner
Journal:  Ann N Y Acad Sci       Date:  1996-01-17       Impact factor: 5.691

Review 6.  Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.

Authors:  A M Schmidt; S D Yan; J L Wautier; D Stern
Journal:  Circ Res       Date:  1999-03-19       Impact factor: 17.367

7.  Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.

Authors:  D Schenk; R Barbour; W Dunn; G Gordon; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; Z Liao; I Lieberburg; R Motter; L Mutter; F Soriano; G Shopp; N Vasquez; C Vandevert; S Walker; M Wogulis; T Yednock; D Games; P Seubert
Journal:  Nature       Date:  1999-07-08       Impact factor: 49.962

8.  A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.

Authors:  C Janus; J Pearson; J McLaurin; P M Mathews; Y Jiang; S D Schmidt; M A Chishti; P Horne; D Heslin; J French; H T Mount; R A Nixon; M Mercken; C Bergeron; P E Fraser; P St George-Hyslop; D Westaway
Journal:  Nature       Date:  2000 Dec 21-28       Impact factor: 49.962

9.  Widespread peroxynitrite-mediated damage in Alzheimer's disease.

Authors:  M A Smith; P L Richey Harris; L M Sayre; J S Beckman; G Perry
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

10.  'In vitro' amyloid fibril formation from transthyretin: the influence of ions and the amyloidogenicity of TTR variants.

Authors:  M J Bonifácio; Y Sakaki; M J Saraiva
Journal:  Biochim Biophys Acta       Date:  1996-05-24
View more
  42 in total

Review 1.  The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.

Authors:  A M Schmidt; S D Yan; S F Yan; D M Stern
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

2.  Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy.

Authors:  Ricardo Gomes; Marta Sousa Silva; Alexandre Quintas; Carlos Cordeiro; António Freire; Paulino Pereira; Américo Martins; Estela Monteiro; Eduardo Barroso; Ana Ponces Freire
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

3.  Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro.

Authors:  Mónica Mendes Sousa; Rui Fernandes; Joana Almeida Palha; Ana Taboada; Paulo Vieira; Maria João Saraiva
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

4.  Human TTRV30M localization within podocytes in a transgenic mouse model of transthyretin related amyloidosis: does the environment play a role?

Authors:  Ioannis Petrakis; Vasiliki Mavroeidi; Kostas Stylianou; George Efthymiou; Kostas Perakis; Eleftheria Vardaki; Spyridon Stratigis; Kostas Giannakakis; Kostas Kourouniotis; George Amoiridis; Andreas Plaitakis; Maria Joao Saraiva; Ken Ichi Yamamura; Eugene Daphnis
Journal:  Transgenic Res       Date:  2012-07-18       Impact factor: 2.788

Review 5.  A brief overview of amyloids and Alzheimer's disease.

Authors:  Sian-Yang Ow; Dave E Dunstan
Journal:  Protein Sci       Date:  2014-07-30       Impact factor: 6.725

Review 6.  Advances in protein misfolding, amyloidosis and its correlation with human diseases.

Authors:  Debanjan Kundu; Kumari Prerna; Rahul Chaurasia; Manoj Kumar Bharty; Vikash Kumar Dubey
Journal:  3 Biotech       Date:  2020-04-04       Impact factor: 2.406

Review 7.  A review on mechanism of inhibition of advanced glycation end products formation by plant derived polyphenolic compounds.

Authors:  Shehwaz Anwar; Shifa Khan; Ahmad Almatroudi; Amjad Ali Khan; Mohammed A Alsahli; Saleh A Almatroodi; Arshad Husain Rahmani
Journal:  Mol Biol Rep       Date:  2021-01-03       Impact factor: 2.316

8.  The S100B/RAGE Axis in Alzheimer's Disease.

Authors:  Estelle Leclerc; Emmanuel Sturchler; Stefan W Vetter
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-21

9.  Quantitative sensation and autonomic test abnormalities in transthyretin amyloidosis polyneuropathy.

Authors:  Dong Hwee Kim; Steven R Zeldenrust; Phillip A Low; Peter J Dyck
Journal:  Muscle Nerve       Date:  2009-09       Impact factor: 3.217

10.  Purple sweet potato color ameliorates cognition deficits and attenuates oxidative damage and inflammation in aging mouse brain induced by d-galactose.

Authors:  Qun Shan; Jun Lu; Yuanlin Zheng; Jing Li; Zhong Zhou; Bin Hu; Zifeng Zhang; Shaohua Fan; Zhen Mao; Yong-Jian Wang; Daifu Ma
Journal:  J Biomed Biotechnol       Date:  2009-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.